Cargando…
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer
In locally advanced rectal cancer a preoperative predictive biomarker is necessary to adjust treatment specifically for those patients expected to suffer relapse. We applied whole genome methylation CpG island array analyses to an initial set of patients (n=11) to identify differentially methylated...
Autores principales: | Gaedcke, Jochen, Leha, Andreas, Claus, Rainer, Weichenhan, Dieter, Jung, Klaus, Kitz, Julia, Grade, Marian, Wolff, Hendrik A., Jo, Peter, Doyen, Jérôme, Gérard, Jean-Pierre, Johnsen, Steven A., Plass, Christoph, Beißbarth, Tim, Ghadimi, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226671/ https://www.ncbi.nlm.nih.gov/pubmed/25261372 |
Ejemplares similares
-
Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
por: Azizian, Azadeh, et al.
Publicado: (2016) -
The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies
por: Grade, Marian, et al.
Publicado: (2012) -
Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
por: Flebbe, Hannah, et al.
Publicado: (2019) -
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017) -
Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)